Amedisys, Inc. (AMED)
Aug 14, 2025 - AMED was delisted (reason: acquired by UNH)
100.99
+0.01 (0.01%)
Inactive · Last trade price on Aug 14, 2025
Amedisys Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 2,402 | 2,348 | 2,236 | 2,223 | 2,214 | 2,072 |
Revenue Growth | 4.92% | 5.00% | 0.59% | 0.41% | 6.88% | 5.93% |
Gross Profit Gross Profit Growth | 1,038 | 1,018 | 990.87 | 962.77 | 980.76 | 886.15 |
Operating Income Operating Income Growth | 226.03 | 209.57 | 193.07 | 183.78 | 238.62 | 189.05 |
Net Income Net Income Growth | 85.63 | 43.23 | -9.75 | 118.61 | 209.07 | 183.61 |
Earnings Per Share EPS Growth | 2.58 | 1.31 | -0.30 | 3.63 | 6.34 | 5.52 |
EPS Growth | -8.17% | - | - | -42.74% | 14.85% | 43.75% |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Other Other Growth | -0.01 | 0.02 | -0.02 | -0 | 0.01 | 0.02 |
Home Health Home Health Growth | 1,506 | 1,491 | 1,404 | 1,362 | 1,354 | 1,249 |
Hospice Hospice Growth | 831 | 825.8 | 798.8 | 787.8 | 791.8 | 750.1 |
Personal Care Personal Care Growth | - | - | 15 | 61.4 | 65 | 72.2 |
High Acuity Care High Acuity Care Growth | 35 | 32 | 19 | 12.3 | 3.5 | - |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 337.3 | 303.24 | 126.45 | 40.54 | 42.69 | 81.81 |
Total Debt Total Debt Growth | 450.51 | 459.3 | 487.21 | 537.94 | 545.61 | 307.04 |
Net Cash (Debt) Net Cash Growth | -113.2 | -156.06 | -360.76 | -497.4 | -502.92 | -225.23 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.41 | -4.72 | -11.07 | -15.23 | -15.25 | -6.77 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | 239.43 | 221.67 | 137.19 | 133.28 | 188.89 | 288.95 |
Capital Expenditures CapEx Growth | -4.41 | -6.55 | -5.62 | -6.17 | -6.3 | -5.33 |
Free Cash Flow Free Cash Flow Growth | 235.02 | 215.12 | 131.57 | 127.12 | 182.59 | 283.62 |
Free Cash Flow Growth | 163.17% | 63.50% | 3.50% | -30.38% | -35.62% | 46.11% |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 43.19% | 43.34% | 44.31% | 43.31% | 44.30% | 42.78% |
Operating Margin | 9.41% | 8.92% | 8.63% | 8.27% | 10.78% | 9.13% |
Pretax Margin | 6.21% | 3.67% | 1.77% | 7.21% | 12.66% | 10.18% |
Profit Margin | 3.56% | 1.84% | -0.44% | 5.33% | 9.44% | 8.86% |
FCF Margin | 9.78% | 9.16% | 5.88% | 5.72% | 8.25% | 13.69% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | - | 68.79 | - | 22.89 | 25.24 | 52.42 |
P/FCF Ratio | - | 13.82 | 23.58 | 21.35 | 28.90 | 33.93 |
PS Ratio | - | 1.27 | 1.39 | 1.22 | 2.38 | 4.65 |